Collegium Pharmaceutical Inc (COLL) — Net Asset Quality Index
Collegium Pharmaceutical Inc (COLL) has a Net Asset Quality Index of 17.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.61 Billion minus total liabilities of $1.33 Billion yields net assets of $274.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Collegium Pharmaceutical Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Collegium Pharmaceutical Inc Net Asset Quality Index Over Time (2013–2024)
This chart shows how Collegium Pharmaceutical Inc's Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at 17.1%, representing net assets of $274.81 Million against total assets of $1.61 Billion USD. See how liquid is Collegium Pharmaceutical Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Collegium Pharmaceutical Inc (2013–2024)
The table below presents the year-by-year Net Asset Quality Index for Collegium Pharmaceutical Inc from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Collegium Pharmaceutical Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 13.8% | $228.84 Million | $1.66 Billion | $1.43 Billion | ▼ -3.3 pp |
| 2023 | 17.1% | $195.43 Million | $1.14 Billion | $947.88 Million | ▲ +0.5 pp |
| 2022 | 16.6% | $194.84 Million | $1.17 Billion | $979.29 Million | ▼ -12.7 pp |
| 2021 | 29.3% | $202.93 Million | $692.08 Million | $489.15 Million | ▲ +0.4 pp |
| 2020 | 28.9% | $186.03 Million | $643.84 Million | $457.81 Million | ▲ +0.3 pp |
| 2019 | 28.5% | $87.43 Million | $306.30 Million | $218.87 Million | ▼ -2.9 pp |
| 2018 | 31.4% | $91.58 Million | $291.25 Million | $199.66 Million | ▼ -45.3 pp |
| 2017 | 76.8% | $104.08 Million | $135.57 Million | $31.49 Million | ▼ -6.5 pp |
| 2016 | 83.3% | $134.91 Million | $162.02 Million | $27.11 Million | ▼ -3.8 pp |
| 2015 | 87.1% | $85.07 Million | $97.72 Million | $12.65 Million | ▲ +327.5 pp |
| 2014 | -240.5% | $-12.24 Million | $5.09 Million | $17.33 Million | ▼ -302.3 pp |
| 2013 | 61.8% | $5.58 Million | $9.03 Million | $3.45 Million | — |